Literature DB >> 12619161

Characterization of the recurrent translocation t(1;1)(p36.3;q21.1-2) in non-Hodgkin lymphoma by multicolor banding and fluorescence in situ hybridization analysis.

Valia S Lestou1, Olga Ludkovski, Joseph M Connors, Randy D Gascoyne, Wan L Lam, Douglas E Horsman.   

Abstract

Aberrations of chromosomal bands 1p36 and 1q11-q23 are among the most common chromosomal alterations in non-Hodgkin lymphoma (NHL). In this study, 16 cases of NHL showing recurrent unbalanced translocation t(1;1)(p36;q11-23) by G-band analysis were selected for further analysis. To delineate the exact breakpoints, multicolor band analysis for chromosome 1 (M-BAND1), and locus-specific fluorescence in situ hybridization (LS-FISH) using human genome designated BAC clones were performed. In all but one dicentric case, the breakpoint was determined to involve chromosomal bands 1p36.3 and 1q21.1-2. LS-FISH analysis for the TP73, MEL1, SKI, and CASP9 loci at 1p36, and the loci IRTA1, IRTA2, BCL9, AF1Q, JTB, and MUC1 at 1q21, verified the MBAND1 results and further delineated the breakpoints. In band 1p36, two hybridization patterns were observed, one involving deletions of MEL1, TP73, and SKI, but not CASP9, and the second involving a breakpoint telomeric to TP73. In region 1q21, four hybridization patterns were observed, the first involving duplication/translocation of all five genes; the second involving duplication/translocation of BCL9, AF1Q, JTB, and MUC1; the third involving duplication/translocation of AF1Q, JTB, and MUC1; and the fourth with a breakpoint telomeric to MUC1. Using an alpha-satellite probe for chromosome 1 (D1Z5), centromeric involvement in the unbalanced translocation t(1;1)(p36.3;q21.1-2) was excluded in all but the one dicentric case, that is, dic(1;1)(p36.3;q10). In conclusion, deletion of 1p36 and duplication of 1q21 through formation of an unbalanced translocation t(1;1)(p36.3;q21.1-2) is a non-random event in NHL, suggesting a deletion-duplication mechanism involved in lymphoma progression and justifying further systematic research. Copyright 2003 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2003        PMID: 12619161     DOI: 10.1002/gcc.10181

Source DB:  PubMed          Journal:  Genes Chromosomes Cancer        ISSN: 1045-2257            Impact factor:   5.006


  10 in total

1.  Recent Advances in Diagnosis of Cancer.

Authors:  J R Bhardwaj
Journal:  Med J Armed Forces India       Date:  2011-07-21

2.  AF1q/MLLT11 regulates the emergence of human prothymocytes through cooperative interaction with the Notch signaling pathway.

Authors:  Aude Parcelier; Nesrine Maharzi; Marc Delord; Macarena Robledo-Sarmiento; Elisabeth Nelson; Halima Belakhdar-Mekid; Marika Pla; Klaudia Kuranda; Veronique Parietti; Michele Goodhardt; Nicolas Legrand; Irwin D Bernstein; Jean Claude Gluckman; François Sigaux; Bruno Canque
Journal:  Blood       Date:  2011-06-28       Impact factor: 22.113

3.  Gene mining: a novel and powerful ensemble decision approach to hunting for disease genes using microarray expression profiling.

Authors:  Xia Li; Shaoqi Rao; Yadong Wang; Binsheng Gong
Journal:  Nucleic Acids Res       Date:  2004-05-17       Impact factor: 16.971

4.  FCRL1 on chronic lymphocytic leukemia, hairy cell leukemia, and B-cell non-Hodgkin lymphoma as a target of immunotoxins.

Authors:  Xing Du; Satoshi Nagata; Tomoko Ise; Maryalice Stetler-Stevenson; Ira Pastan
Journal:  Blood       Date:  2007-09-25       Impact factor: 22.113

5.  Differential expression of S100 gene family in human esophageal squamous cell carcinoma.

Authors:  Junfang Ji; Liqun Zhao; Xiuqin Wang; Chuannong Zhou; Fang Ding; Lei Su; Chunlin Zhang; Xuezheng Mao; Min Wu; Zhihua Liu
Journal:  J Cancer Res Clin Oncol       Date:  2004-06-04       Impact factor: 4.553

6.  Refinement of 1p36 alterations not involving PRDM16 in myeloid and lymphoid malignancies.

Authors:  Francois P Duhoux; Geneviève Ameye; Virginie Lambot; Christian Herens; Frédéric Lambert; Sophie Raynaud; Iwona Wlodarska; Lucienne Michaux; Catherine Roche-Lestienne; Elise Labis; Sylvie Taviaux; Elise Chapiro; Florence Nguyen-Khac; Florence Nguyen Khac; Stéphanie Struski; Sophie Dobbelstein; Nicole Dastugue; Eric Lippert; Frank Speleman; Nadine Van Roy; An De Weer; Katrina Rack; Pascaline Talmant; Steven Richebourg; Francine Mugneret; Isabelle Tigaud; Marie-Joëlle Mozziconacci; Sophy Laibe; Nathalie Nadal; Christine Terré; Jeanne-Marie Libouton; Anabelle Decottignies; Miikka Vikkula; Hélène A Poirel
Journal:  PLoS One       Date:  2011-10-21       Impact factor: 3.240

7.  Burkitt-Type Acute Lymphoblastic Leukemia With Precursor B-Cell Immunophenotype and Partial Tetrasomy of 1q: A Case Report.

Authors:  Yuya Sato; Hidemitsu Kurosawa; Keitaro Fukushima; Mayuko Okuya; Osamu Arisaka
Journal:  Medicine (Baltimore)       Date:  2016-03       Impact factor: 1.889

8.  Involvement of AF1q/MLLT11 in the progression of ovarian cancer.

Authors:  Paola Tiberio; Ludmila Lozneanu; Valentina Angeloni; Elena Cavadini; Patrizia Pinciroli; Maurizio Callari; Maria Luisa Carcangiu; Domenica Lorusso; Francesco Raspagliesi; Valentina Pala; Maria Grazia Daidone; Valentina Appierto
Journal:  Oncotarget       Date:  2017-04-04

9.  Prognostic significance of Fc receptor-like 1 in patients with chronic lymphocytic leukemia, hairy cell leukemia, and various B-cell non-Hodgkin's lymphoma.

Authors:  Zahra Yousefi; Nahid Eskandari
Journal:  Leuk Res Rep       Date:  2019-08-14

10.  FISH analysis of hematological neoplasias with 1p36 rearrangements allows the definition of a cluster of 2.5 Mb included in the minimal region deleted in 1p36 deletion syndrome.

Authors:  Idoya Lahortiga; Iria Vázquez; Elena Belloni; José P Román; Patrizia Gasparini; Francisco J Novo; Isabel Zudaire; Pier G Pelicci; Jesús M Hernández; María J Calasanz; María D Odero
Journal:  Hum Genet       Date:  2005-03-03       Impact factor: 4.132

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.